Remove 2001 Remove Communication Remove Vaccines
article thumbnail

IGI and AbbVie sign licence deal for cancer and autoimmune therapy

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out? July 11, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook AbbVie will gain exclusive rights to develop, manufacture and market ISB 2001 across several major regions. Credit: JHVEPhoto/Shutterstock. Don’t let policy changes catch you off guard.

article thumbnail

UK steps up with £1.25bn Gavi vaccine pledge as US funding disappears

Pharmaceutical Technology

The UK has confirmed its support for global vaccination by pledging £1.25bn to global vaccine group Gavi while the US will halt funding to the international organisation. The Gates Foundation committed $1.6bn for the vaccine alliance, making it the second largest donor. Credit: speedshutter Photography via Shutterstock.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 steps for comprehensive patient collaboration

pharmaphorum

He joined Johnson & Johnson in 2001 as Director Corporate Communications. In 2006 he joined the Janssen teams working in Infectious Diseases where he helped to maintain and enhance the company’s relationships with the HIV Patient Community. About the author. In that function, he initially worked in the field of oncology.

article thumbnail

Independent health comms agencies rebrand with emphasis on authenticity

pharmaphorum

In a world of a million messages, should authenticity be the common thread tying all pharma communications and marketing activities together? Authentic, knowledgeable communications designed and executed by authentic, knowledgeable professionals is the key to pharma’s success in today’s media landscape. Authentic communications.

article thumbnail

OVID Health appoints high-profile leaders as senior counsel

pharmaphorum

Independent communications agency OVID Health has appointed Niall Dickson, professor David Salisbury and Athena Lamnisos as senior counsel, providing strategic advice and thought leadership across several projects involving healthcare and pharma clients. He was made a Companion of the Order of the Bath in 2001.

article thumbnail

Accommodating Multiple Modalities in the Same Facility

ISPE

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

article thumbnail

Can amoxicillin treat STDs?

The Checkup by Singlecare

In a 2001 study that compared azithromycin to amoxicillin for the treatment of chlamydia in pregnancy, cure rates of both drugs were high. This can be done in several ways, including abstaining from sexual activity, vaccination, and mutual monogamy. Many STDs can be cured with the proper treatment.

Dosage 97